NCT02713061View on ClinicalTrials.gov

A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult Participants

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

March 31, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Influenza Prevention

Interventions

DRUG

TAK-850

TAK-850 injection

Trial Locations (1)

Unknown

Toshima-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY